Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.

British Journal of Pharmacology
J E SounessR Jordan

Abstract

1. The mechanism by which M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine (MIMAX), which have been described as selective cyclic GMP phosphodiesterase (PDE) inhibitors, relax rat aorta was investigated. 2. Three cyclic nucleotide PDEs were identified in the soluble fraction of rat aorta; a Ca2+-insensitive form exhibiting substrate selectivity for cyclic GMP (cGMP PDE), a Ca2+/calmodulin-stimulated form which also preferentially hydrolyzed cyclic GMP (Ca2+ PDE), and a form demonstrating substrate selectivity for cyclic AMP (cAMP PDE). 3. M&B 22,948 and MIMAX inhibited cGMP PDE (Ki = 0.16 microM and 0.43 microM, respectively) and Ca2+ PDE (Ki = 9.9 microM and 0.55 microM, respectively), but exhibited weak activity against cAMP PDE (Ki = 249 microM and 42 microM, respectively). MY-5445 selectivity inhibited cGMP PDE (Ki = 1.3 microM) and vinpocetine selectively inhibited Ca2+ PDE (Ki = 14 microM). 4. M&B 22,948 and MIMAX induced dose-dependent increases in the accumulation of cyclic GMP, but not cyclic AMP, in rat aorta pieces. These effects were greatly reduced by endothelial denudation and by methylene blue (5 microM) which blocks the actions of endothelium-derived relaxant factor. MY-5445 and v...Continue Reading

References

Jul 1, 1986·The Journal of Clinical Investigation·F Murad
Feb 1, 1984·Biochemical Pharmacology·M HagiwaraH Hidaka
Apr 1, 1984·British Journal of Pharmacology·A Bowman, A H Drummond

❮ Previous
Next ❯

Citations

Nov 9, 1995·Biochemical Pharmacology·H Coste, P Grondin
Jan 10, 1991·European Journal of Pharmacology·D H MauriceR J Haslam
Jul 23, 1991·European Journal of Pharmacology·M KuhnU Förstermann
Nov 16, 1993·European Journal of Pharmacology·R L DundoreE D Pagani
Mar 24, 1995·European Journal of Pharmacology·A J Barbier, R A Lefebvre
Jan 1, 1991·Pharmacology & Therapeutics·W J Thompson
Aug 15, 1993·European Journal of Pharmacology·T IsonoM Ohtsuka
Jun 20, 2001·European Journal of Pharmacology·C KruuseL Edvinsson
Nov 27, 2002·European Journal of Pharmacology·Hideki MochidaKohei Kikkawa
Dec 13, 2000·Brain Research Bulletin·P BönöczkA Vas
Dec 25, 2003·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Takayuki MatsumotoKatsuo Kamata
Oct 23, 1998·Current Problems in Pediatrics·J W Skimming
Apr 18, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J KoteraK Omori
Mar 29, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bing ZhuTroy Stevens
May 24, 2006·Expert Review of Cardiovascular Therapy·Anna R Hemnes, Hunter C Champion
Nov 14, 1997·The Journal of General Physiology·D H Hackos, J I Korenbrot
Oct 3, 1998·The Journal of Biological Chemistry·J KoteraK Omori
Nov 15, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Oleg V EvgenovFumito Ichinose

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.